Literature DB >> 3495801

Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus.

T C Chanh, G R Dreesman, R C Kennedy.   

Abstract

A monoclonal anti-idiotypic (anti-Id) antibody, HF1.7, was generated against anti-Leu-3a, a mouse monoclonal antibody (mAb) specific for the CD4 molecule on human helper/inducer T lymphocytes. The anti-Id nature of HF1.7 was demonstrated by the following properties. (i) It reacted in a solid-phase immunoassay with anti-Leu-3a and not with a panel of irrelevant mouse mAbs. (ii) It partially inhibited the binding of anti-Leu-3a to CD4+ T cells. (iii) It detected a common idiotype present on various anti-CD4 mAbs. Because the CD4 molecule represents the receptor site for human immunodeficiency virus (HIV), the etiologic viral agent of acquired immunodeficiency syndrome, we examined the ability of the anti-mAb HF1.7 to mimic CD4 and bind HIV. This anti-Id mAb reacted with HIV antigens in commercial HIV ELISAs and recognized HIV-infected human T cells but not uninfected cells when analyzed by flow cytofluorometry. Attesting further to the HIV specificity, the anti-Id mAb reacted with a recombinant gp160 peptide and a molecule of Mr 110,000-120,000 in immunoblot analysis of HIV-infected cell lysates. The anti-Id mAb also partially neutralized HIV infection of human T cells in vitro. These results strongly suggest that this anti-Id mAb mimics the CD4 antigenic determinants involved in binding to HIV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495801      PMCID: PMC304982          DOI: 10.1073/pnas.84.11.3891

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Idiotypic mimicry of biological receptors.

Authors:  G N Gaulton; M I Greene
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

2.  Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

Authors:  S Benn; R Rutledge; T Folks; J Gold; L Baker; J McCormick; P Feorino; P Piot; T Quinn; M Martin
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

3.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

5.  Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.

Authors:  J S McDougal; J K Nicholson; G D Cross; S P Cort; M S Kennedy; A C Mawle
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  Anti-idiotypes and immunity.

Authors:  R C Kennedy; J L Melnick; G R Dreesman
Journal:  Sci Am       Date:  1986-07       Impact factor: 2.142

7.  Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

Authors:  R C Kennedy; R D Henkel; D Pauletti; J S Allan; T H Lee; M Essex; G R Dreesman
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

8.  Antiidiotypic antibody to reovirus binds to neurons and protects from viral infection.

Authors:  M A Dichter; H L Weiner; B N Fields; G Mitchell; J Noseworthy; G Gaulton; M Greene
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

9.  Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees.

Authors:  R C Kennedy; J W Eichberg; R E Lanford; G R Dreesman
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

10.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.

Authors:  J S McDougal; A Mawle; S P Cort; J K Nicholson; G D Cross; J A Scheppler-Campbell; D Hicks; J Sligh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  11 in total

1.  An antibody as surrogate receptor reveals determinants of activity of an innate immune peptide antibiotic.

Authors:  Suvendu Lomash; Sushma Nagpal; Dinakar M Salunke
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

2.  Current approaches to vaccine preparation.

Authors:  J J Liu; A Cepica
Journal:  Can Vet J       Date:  1990-03       Impact factor: 1.008

3.  Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.

Authors:  L D Papsidero; M Sheu; F W Ruscetti
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.

Authors:  T Mizukami; T R Fuerst; E A Berger; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 5.  Idiotypic vaccines and infectious diseases.

Authors:  J R Hiernaux
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

Review 6.  Anti-idiotypic antibodies as vaccines against carbohydrate antigens.

Authors:  M A Westerink; M A Apicella
Journal:  Springer Semin Immunopathol       Date:  1993

7.  Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.

Authors:  D Schols; M Baba; R Pauwels; J Desmyter; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

Authors:  M Kowalski; B Ardman; L Basiripour; Y C Lu; D Blohm; W Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Anti-idiotypic antibodies to bovine herpesvirus-1 inhibit virus infection in cell cultures.

Authors:  O Y AbdelMagid; D J Orten; W Xue; F Blecha; H C Minocha
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia.

Authors:  S Karpatkin; M A Nardi; Y H Kouri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.